Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+21.9%
5Y CAGR+42.2%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+21.9%/yr
vs +92.5%/yr prior
5Y CAGR
+42.2%/yr
Recent deceleration
Acceleration
-70.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.8x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $252.15M | +58.2% |
| 2024 | $159.42M | -17.1% |
| 2023 | $192.36M | +38.1% |
| 2022 | $139.30M | +71.1% |
| 2021 | $81.41M | +87.7% |
| 2020 | $43.37M | -4.8% |
| 2019 | $45.55M | +349.3% |
| 2018 | $10.14M | -67.5% |
| 2017 | $31.15M | -6.2% |
| 2016 | $33.21M | - |